rs61742871
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_002334.4(LRP4):c.3064A>G(p.Asn1022Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,614,078 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002334.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cenani-Lenz syndactyly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- congenital myasthenic syndrome 17Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- sclerosteosis 2Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP4 | NM_002334.4 | c.3064A>G | p.Asn1022Asp | missense_variant | Exon 22 of 38 | ENST00000378623.6 | NP_002325.2 | |
LRP4 | XM_017017734.2 | c.3064A>G | p.Asn1022Asp | missense_variant | Exon 22 of 39 | XP_016873223.1 | ||
LRP4 | XM_011520103.3 | c.2260A>G | p.Asn754Asp | missense_variant | Exon 16 of 32 | XP_011518405.1 | ||
LRP4 | XM_011520104.3 | c.829A>G | p.Asn277Asp | missense_variant | Exon 7 of 23 | XP_011518406.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000940 AC: 143AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00102 AC: 257AN: 251466 AF XY: 0.00102 show subpopulations
GnomAD4 exome AF: 0.00110 AC: 1610AN: 1461888Hom.: 2 Cov.: 32 AF XY: 0.00104 AC XY: 754AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.000940 AC: 143AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000767 AC XY: 57AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function -
Cenani-Lenz syndactyly syndrome Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
LRP4-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at